The rising prevalence in GLP-1 agonists for metabolic conditions has led to a discussion about delivery methods : transdermal systems versus pills . Typically, GLP-1 drugs were solely available in oral https://sidneygprz207174.alltdesign.com/glp-1-transdermal-delivery-systems-vs-oral-medications-what-best-for-the-patient-59688156